Related Experiment Videos
T-cell interactions with extracellular matrix proteins in allograft rejection: target for immunomodulating therapy
A Górski1, B Stepień-Sopniewska, L Paczek
1Warsaw Medical School, Warsaw, Poland.
Transplantation Proceedings
|December 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Magnetic Circular Dichroism of meso-Phenyl-Substituted Pd-Octaethylporphyrins.
The journal of physical chemistry. A·2020
Therapeutic potential of phages in autoimmune liver diseases.
Clinical and experimental immunology·2017
Activity of Zn and Mg phthalocyanines and porphyrazines in amyloid aggregation of insulin.
Journal of molecular recognition : JMR·2017
Resonance Raman spectroscopy study of protonated porphyrin.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2016
Phages in the global fruit and vegetable industry.
Journal of applied microbiology·2014
Successful Heart and Renal Allograft Transplantation From Patients With Child-Pugh Class C Cirrhosis.
Transplantation proceedings·2026
Empagliflozin Alleviates Renal Ischemia-Reperfusion Injury by Targeting AMPK/NLRP3 Signaling.
Transplantation proceedings·2026
Risk-Stratified 2 mg/kg ATG Induction in Kidney Transplantation: Comparing Two- and Three-Dose Regimens at a Single Center.
Transplantation proceedings·2026
Regulatory T cells in intracerebral hemorrhage: mechanisms of immunomodulation and therapeutic potential.
Frontiers in immunology·2026
Fc-engineering for improved cancer immunotherapy.
Biochemical Society transactions·2026
Explosive Multiterritorial Arterial Thrombosis Following Brief Heparin Exposure: A Diagnostic Pitfall in the Cath Lab.
Case reports in cardiology·2026
Lipophilic Ligand Efficiency-Monitored Discovery of Potent, Achiral, and Bioavailable Apo-IDO1 Inhibitors.
ACS medicinal chemistry letters·2026
Telitacicept for IgA nephropathy: a systematic review and meta-analysis of observational studies.
Frontiers in medicine·2026
Envafolimab - novel anti-PD-1/PD-L1 antibody in cancer treatment.
Frontiers in immunology·2026